中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

内镜超声在肝癌诊治中的应用进展

刘攀 于守君 成雨

刘攀,于守君,成雨. 内镜超声在肝癌诊治中的应用进展[J]. 临床肝胆病杂志, 2021, 37(8): 1934-1937. DOI: 10.3969/j.issn.1001-5256.2021.08.041
引用本文: 刘攀,于守君,成雨. 内镜超声在肝癌诊治中的应用进展[J]. 临床肝胆病杂志, 2021, 37(8): 1934-1937. DOI: 10.3969/j.issn.1001-5256.2021.08.041
LIU P, YU SJ, CHENG Y. Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer[J]. J Clin Hepatol, 2021, 37(8): 1934-1937. DOI: 10.3969/j.issn.1001-5256.2021.08.041
Citation: LIU P, YU SJ, CHENG Y. Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer[J]. J Clin Hepatol, 2021, 37(8): 1934-1937. DOI: 10.3969/j.issn.1001-5256.2021.08.041

内镜超声在肝癌诊治中的应用进展

DOI: 10.3969/j.issn.1001-5256.2021.08.041
详细信息
    通讯作者:

    于守君,1224267547@qq.com

  • 中图分类号: R735.7

Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer

  • 摘要: 肝癌是我国最常见的恶性肿瘤之一,其发病率呈逐年上升趋势。因此,肝癌的早期诊断和治疗显得尤为重要,在诸多检查中,内镜超声(EUS)可以对肝脏和胆道系统进行近距离的扫描,对肝癌的诊断、治疗和分期起着不可或缺的作用。现概述EUS在肝癌诊断和治疗中的应用现状及前景,以期为临床肝癌的诊治提供参考。

     

  • [1] WU M, LIU Z, LI X, et al. Dynamic changes in serum markers and their utility in the early diagnosis of all stages of hepatitis B-associated hepatocellular carcinoma[J]. Onco Targets Ther, 2020, 13: 827-840. DOI: 10.2147/OTT.S229835.
    [2] HENNEDIGE T, VENKATESH SK. Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring[J]. Cancer Imaging, 2013, 12: 530-547. DOI: 10.1102/1470-7330.2012.0044.
    [3] SINGH P, MUKHOPADHYAY P, BHATT B, et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: Results of a prospective comparative study[J]. J Clin Gastroenterol, 2009, 43(4): 367-373. DOI: 10.1097/MCG.0b013e318167b8cc.
    [4] ICHIM VA, CHIRA RI, MIRCEA PA, et al. Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions[J]. Med Ultrason, 2020, 22(1): 20-25. DOI: 10.11152/mu-2078.
    [5] SINGH P, ERICKSON RA, MUKHOPADHYAY P, et al. EUS for detection of the hepatocellular carcinoma: Results of a prospective study[J]. Gastrointest Endosc, 2007, 66(2): 265-273. DOI: 10.1016/j.gie.2006.10.053.
    [6] LANGE A, MUNIRAJ T, ASLANIAN HR. Endoscopic ultrasound for the diagnosis and staging of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 339-350. DOI: 10.1016/j.giec.2018.12.005.
    [7] BEYER LP, WASSERMANN F, PREGLER B, et al. Characterization of focal liver lesions using CEUS and MRI with liver-specific contrast media: Experience of a single radiologic center[J]. Ultraschall Med, 2017, 38(6): 619-625. DOI: 10.1055/s-0043-105264.
    [8] OH D, SEO DW, HONG SM, et al. The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video)[J]. Gastrointest Endosc, 2018, 88(3): 495-501. DOI: 10.1016/j.gie.2018.05.019.
    [9] MINAGA K, KITANO M, NAKAI A, et al. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video)[J]. Gastrointest Endosc, 2021, 93(2): 433-441. DOI: 10.1016/j.gie.2020.06.051.
    [10] JOHNSON KD, LAOVEERAVAT P, YEE EU, et al. Endoscopic ultrasound guided liver biopsy: Recent evidence[J]. World J Gastrointest Endosc, 2020, 12(3): 83-97. DOI: 10.4253/wjge.v12.i3.83.
    [11] SHUJA A, ALKHASAWNEH A, FIALHO A, et al. Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies[J]. Dig Liver Dis, 2019, 51(6): 826-830. DOI: 10.1016/j.dld.2019.01.006.
    [12] ALI AH, PANCHAL S, RAO DS, et al. The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: A retrospective single-center study[J]. J Ultrasound, 2020, 23(2): 157-167. DOI: 10.1007/s40477-020-00436-z.
    [13] BHATIA V, VARADARAJULU S. Endoscopic ultrasonography-guided tissue acquisition: How to achieve excellence[J]. Dig Endosc, 2017, 29(4): 417-430. DOI: 10.1111/den.12823.
    [14] NGUYEN P, FENG JC, CHANG KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions[J]. Gastrointest Endosc, 1999, 50(3): 357-361. DOI: 10.1053/ge.1999.v50.97208.
    [15] OH D, SEO DW, HONG SM, et al. Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass[J]. Endosc Ultrasound, 2017, 6(2): 109-115. DOI: 10.4103/2303-9027.204813.
    [16] CHON HK, YANG HC, CHOI KH, et al. Endoscopic ultrasound-guided liver biopsy using a core needle for hepatic solid mass[J]. Clin Endosc, 2019, 52(4): 340-346. DOI: 10.5946/ce.2018.175.
    [17] CHEN F, BAO H, DENG Z, et al. Endoscopic ultrasound-guided sampling using core biopsy needle for diagnosis of left-lobe hepatocellular carcinoma in patients with underlying cirrhosis[J]. J Cancer Res Ther, 2020, 16(5): 1100-1105. DOI: 10.4103/jcrt.JCRT_723_19.
    [18] SCHULMAN AR, THOMPSON CC, ODZE R, et al. Optimizing EUS-guided liver biopsy sampling: Comprehensive assessment of needle types and tissue acquisition techniques[J]. Gastrointest Endosc, 2017, 85(2): 419-426. DOI: 10.1016/j.gie.2016.07.065.
    [19] CHING-COMPANIONI RA, DIEHL DL, JOHAL AS, et al. 19 G aspiration needle versus 19 G core biopsy needle for endoscopic ultrasound-guided liver biopsy: A prospective randomized trial[J]. Endoscopy, 2019, 51(11): 1059-1065. DOI: 10.1055/a-0956-6922.
    [20] MOHAN BP, SHAKHATREH M, GARG R, et al. Efficacy and safety of EUS-guided liver biopsy: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2019, 89(2): 238-246. DOI: 10.1016/j.gie.2018.10.018.
    [21] RUSTEMOVIC N, HRSTIC I, OPACIC M, et al. EUS elastography in the diagnosis of focal liver lesions[J]. Gastrointest Endosc, 2007, 66(4): 823-824; discussion 824. DOI: 10.1016/j.gie.2007.06.047.
    [22] European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis[J]. J Hepatol, 2015, 63(1): 237-264. DOI: 10.1016/j.jhep.2015.04.006.
    [23] SANDULESCU L, PADUREANU V, DUMITRESCU C, et al. A pilot study of real time elastography in the differentiation of focal liver lesions[J]. Curr Health Sci J, 2012, 38(1): 32-35.
    [24] MA X, ZHAN W, ZHANG B, et al. Elastography for the differentiation of benign and malignant liver lesions: A meta-analysis[J]. Tumour Biol, 2014, 35(5): 4489-4497. DOI: 10.1007/s13277-013-1591-4.
    [25] JIAO Y, DONG F, WANG H, et al. Shear wave elastography imaging for detecting malignant lesions of the liver: A systematic review and pooled meta-analysis[J]. Med Ultrason, 2017, 19(1): 16-22. DOI: 10.11152/mu-925.
    [26] HU X, HUANG X, CHEN H, et al. Diagnostic effect of shear wave elastography imaging for differentiation of malignant liver lesions: A meta-analysis[J]. BMC Gastroenterol, 2019, 19(1): 60. DOI: 10.1186/s12876-019-0976-2.
    [27] SCOPELLITI F, PEA A, CONIGLIARO R, et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer[J]. Surg Endosc, 2018, 32(9): 4022-4028. DOI: 10.1007/s00464-018-6217-x.
    [28] DHALIWAL A, KOLLI S, DHINDSA BS, et al. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis[J]. Endosc Int Open, 2020, 8(10): e1243-e1251. DOI: 10.1055/a-1221-5012.
    [29] de NUCCI G, DELLA CORTE C, REATI R, et al. Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: A case report test for efficacy and future perspectives[J]. Endosc Int Open, 2020, 8(11): e1713-e1716. DOI: 10.1055/a-1236-3105.
    [30] LUCCHINA N, TSETIS D, IERARDI AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas[J]. Ann Gastroenterol, 2016, 29(4): 460-465. DOI: 10.20524/aog.2016.0066.
    [31] CHUA T, FAIGEL DO. Endoscopic ultrasound-guided ablation of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 369-379. DOI: 10.1016/j.giec.2018.11.007.
    [32] LU J, ZHU HD, TENG GJ, et al. Role of interventional therapy in the downstaging of advanced liver cancer[J]. J Clin Hepatol, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006.

    陆建, 朱海东, 滕皋军, 等. 介入治疗在中晚期肝癌降期中的作用[J]. 临床肝胆病杂志, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006.
    [33] WEIS S, FRANKE A, BERG T, et al. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma[J]. Cochrane Database Syst Rev, 2015, 1: CD006745. DOI: 10.1002/14651858.CD006745.pub3.
    [34] CHOI JH, PARK DH, KIM MH, et al. Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors[J]. Dig Endosc, 2018, 30(5): 652-658. DOI: 10.1111/den.13058.
    [35] TEOH AY, CHONG CC, CHAN AW, et al. EUS-guided alcohol injection of pancreatic neuroendocrine tumor[J]. Gastrointest Endosc, 2015, 82(1): 167. DOI: 10.1016/j.gie.2015.01.047.
    [36] XU ZF, XIE XY, CUI Y, et al. Initial clinical experience of ethanol ablation with endoscopic ultrasonography guidance for 10 cases of hepatocellular carcinoma which are difficult to reach by percutaneous mode[J/CD]. Chin J Med Ultrasound (Electronic edition), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015.

    徐作峰, 谢晓燕, 崔毅, 等. 超声内镜引导无水酒精治疗特殊部位肝癌10例[J/CD]. 中华医学超声杂志(电子版), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015.
    [37] NAKAJI S, HIRATA N, KOBAYASHI M, et al. Endoscopic ultrasonography-guided ethanol injection as a treatment for ruptured hepatocellular carcinoma in the left hepatic lobe[J]. Endoscopy, 2015, 47 Suppl 1: e558-e560. DOI: 10.1055/s-0034-1393394.
    [38] NAKAJI S, HIRATA N, MIKATA R, et al. Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe[J]. Endosc Int Open, 2016, 4(10): e1111-e1115. DOI: 10.1055/s-0042-116146.
    [39] SEO DW. EUS-guided antitumor therapy for pancreatic tumors[J]. Gut Liver, 2010, 4 Suppl 1: s76-s81. DOI: 10.5009/gnl.2010.4.S1.S76.
    [40] LEVY MJ, ALBERTS SR, BAMLET WR, et al. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer[J]. Gastrointest Endosc, 2017, 86(1): 161-169. DOI: 10.1016/j.gie.2016.11.014.
    [41] POGGI G, TOSORATTI N, MONTAGNA B, et al. Microwave ablation of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(25): 2578-2589. DOI: 10.4254/wjh.v7.i25.2578.
    [42] DING J, JING X, LIU J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma[J]. Eur J Radiol, 2013, 82(9): 1379-1384. DOI: 10.1016/j.ejrad.2013.04.025.
    [43] SHI J, SUN Q, WANG Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroenterol Hepatol, 2014, 29(7): 1500-1507. DOI: 10.1111/jgh.12572.
    [44] SONG SY, ZHANG S, LIU F, et al. An experimental study on endoscopic ultrasound-guided microwave ablation for porcine liver and pancreas[J]. Chin J Dig Endosc, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008.

    宋世义, 张松, 刘飞, 等. 内镜超声引导下微波消融猪肝脏及胰腺的实验研究[J]. 中华消化内镜杂志, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008.
    [45] JI J, SHI J, BUDHU A, et al. MicroRNA expression, survival, and response to interferon in liver cancer[J]. N Engl J Med, 2009, 361(15): 1437-1447. DOI: 10.1056/NEJMoa0901282.
    [46] CAMPOS S, POLEY JW, van DRIEL L, et al. The role of EUS in diagnosis and treatment of liver disorders[J]. Endosc Int Open, 2019, 7(10): e1262-e1275. DOI: 10.1055/a-0958-2183.
  • 加载中
计量
  • 文章访问数:  35
  • HTML全文浏览量:  27
  • PDF下载量:  13
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-01-02
  • 修回日期:  2021-02-01
  • 刊出日期:  2021-08-16
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回